The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ:GIFT) (the "Company"), the owner and operator of CardCash.com and ...

Based Review of GLP-1/GIP Agonists for Fitness and Wellness ProfessionalsGilbert, AZ, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The ...

Weight loss injections such as Wegovy or Mounjaro work by reducing food cravings. The new guidance will help prevent vulnerable people buying the ‘high-risk’ medications online. New rules will ...

A charity boss from Kent who says weight loss medication changed his life is supporting moves to introduce stricter checks, before the drugs are prescribed by online pharmacies.Neil Charlick ...

Initial screening assays were performed with a large number of typical and atypical antipsychotic drugs ... been most closely linked with weight gain or loss. Comparison of Weight Gain with ...

With the so-called wonder drugs coming under scrutiny, we look at the negative and positive side effects of taking them There has been meteoric demand for the weight loss drug Wegovy since it was ...